These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 6627287)

  • 1. Clinical evaluation of cefamandole in childhood infections.
    Paul RS; Kumar A; Worthington DC; Walton RO
    Clin Ther; 1983; 5(6):617-23. PubMed ID: 6627287
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adverse reactions to parenteral lincomycin.
    Berry DD; Brouhard BH; Box QT
    Pediatrics; 1981 Mar; 67(3):389-91. PubMed ID: 7017577
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacology, Safety, and efficacy of cefamandole in childhood infections.
    Thirumoorthi MC; Dajani AS; Vincent CV; Maurer MJ
    Antimicrob Agents Chemother; 1981 Jul; 20(1):21-4. PubMed ID: 7283413
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Use of cefamandole in the treatment of soft tissue and skeletal infections.
    LeFrock JL; Paparone P; Kowalsky SF; Schell RF; Jacobs RL; Wirth CR; Tillotson JR
    Drug Intell Clin Pharm; 1981 Dec; 15(12):951-7. PubMed ID: 7338190
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical and laboratory investigation of cefamandole therapy of infections in infants and children.
    Azimi PH
    J Infect Dis; 1978 May; 137 Suppl():S155-S160. PubMed ID: 349094
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Cefotaxime in childhood infections (author's transl)].
    Garnier JM; Giraud F
    Nouv Presse Med; 1981 Feb; 10(8):629-33. PubMed ID: 6259608
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical and laboratory evaluation of cefamandole in infants and children.
    Rodriguez WJ; Ross S; Khan WN; Goldenberg R
    J Infect Dis; 1978 May; 137 Suppl():S150-S154. PubMed ID: 306402
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cefamandole in the treatment of serious bone and joint diseases.
    Levine LR
    Scand J Infect Dis Suppl; 1980; suppl 25():89-93. PubMed ID: 7010542
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clindamycin treatment of osteomyelitis and septic arthritis in children.
    Feigin RD; Pickering LK; Anderson D; Keeney RE; Shackleford PG
    Pediatrics; 1975 Feb; 55(2):213-23. PubMed ID: 1118208
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Pediatric experiences with cefamandole nafate].
    Perinotto G; Belloni CL; Robecchi GA; Fiorella G
    Clin Ter; 1981 Apr; 97(2):165-74. PubMed ID: 7237956
    [No Abstract]   [Full Text] [Related]  

  • 11. Clinical experience with cefamandole for treatment of serious bone and joint infections.
    Levine LR; McCain E
    J Infect Dis; 1978 May; 137 Suppl():S119-S124. PubMed ID: 649996
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment of osteomyelitis and septic arthritis with cefamandole.
    Bernstein BM; Fass RJ
    Am J Med Sci; 1982; 284(3):2-8. PubMed ID: 7148886
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Experience with linezolid therapy in children with osteoarticular infections.
    Chen CJ; Chiu CH; Lin TY; Lee ZL; Yang WE; Huang YC
    Pediatr Infect Dis J; 2007 Nov; 26(11):985-8. PubMed ID: 17984803
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Once-daily administration of ceftriaxone for the treatment of selected serious bacterial infections in children.
    Frenkel LD
    Pediatrics; 1988 Sep; 82(3 Pt 2):486-91. PubMed ID: 3405685
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cefamandole alone and combined with gentamicin or tobramycin in the treatment of acute pyelonephritis.
    Gentry LO; Wood BA; Martin MD; Smythe J
    Scand J Infect Dis Suppl; 1980; suppl 25():96-100. PubMed ID: 7010544
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical and laboratory investigation of cefamandole in infections of infants and children.
    Azimi PA
    Antimicrob Agents Chemother; 1978 Jun; 13(6):955-7. PubMed ID: 307939
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The treatment of serious anaerobic infections.
    Greenberg RN; Scalcini MC; Sanders CV; Lewis AC
    Scand J Infect Dis Suppl; 1980; suppl 25():84-8. PubMed ID: 7010541
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bacterial peritonitis. Protecting the high-risk patient.
    Jones LM; Miller S
    Am Surg; 1984 Jul; 50(7):358-61. PubMed ID: 6378000
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Fundamental and clinical studies on cefamandole in pediatric treatment (author's transl)].
    Motohiro T; Sakata Y; Nishiyama T; Nakajima T; Imai H; Ishimoto K; Tominaga K; Yamashita F; Takeya S
    Jpn J Antibiot; 1979 Sep; 32(9):930-7. PubMed ID: 501920
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cefamandole for treatment of obstetrical and gynecological infections.
    Cunningham FG; Gilstrap LC; Kappus SS
    Scand J Infect Dis Suppl; 1980; suppl 25():75-82. PubMed ID: 7010540
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.